LONDON — Novo Nordisk, under new leadership and in need of a boost, said Wednesday it would trim 9,000 jobs — roughly 11% of its workforce — as it seeks to remake itself for a more competitive obesity drug market. The cuts are designed to save the Danish firm $1.26 billion a year by the…
Despite high price tags, the Wegovy and Zepbound obesity drugs are considered to be cost effective, because they help patients lose substantial weight that, in turn, reduces the risk of high blood pressure and diabetes, among other ailments, according to a preliminary analysis. The wildly popular injectable drugs have caused a sensation because they can…
Medical Bulletin 09/September/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Blood pressure matters at all ages. Children with higher blood pressure at age 7 may be at an increased risk of dying of cardiovascular disease by their mid-50s, according to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2025. The meeting is in Baltimore, September 4-7, 2025, and is the premier scientific exchange focused on…
The FDA has set up a ‘green list’ of overseas sources for weight-loss ingredients in an attempt to block illegitimate and potentially unsafe supplies entering the US market. The list identifies sources of GLP-1 active pharmaceutical ingredients (APIs) from plants that operate in compliance with the FDA’s standards for manufacturing practices – based on an…
GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a deal to buy Thirty Madison in an all-stock deal valued at around $500 million. Short Hills, New Jersey-based Remedy Meds is just over a year old, having started operations last year, but has grown swiftly by tapping into…
Women With Metabolic Syndrome Face Higher Odds of Overactive Bladder: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
HOMA-IR Identified as Independent Predictor of Liver Fibrosis in MAFLD, suggests study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Treating Heart Failure with Anti-Obesity Medication: Dual Benefits for Clinical Outcomes and Climate Impact We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link